Isabelle Cleynen
- Genetics top 1%
- Inflammatory Bowel Disease 60
- Immunology top 2%
- Immunodeficiency and Autoimmune Disorders 14
- Gastroenterology top 2%
- Epidemiology top 2%
- Microscopic Colitis 29
- Autoimmune and Inflammatory Disorders 9
- Cancer Research top 5%
-
- Helicobacter pylori-related gastroenterology studies 21
- Eosinophilic Esophagitis 7
-
- Gut microbiota and health 6
-
- Alzheimer's disease research and treatments 5
- Co-authors
- Séverine VermeirePaul RutgeertsWim Van de VenGert Van AsscheMarc FerranteKristel Van SteenBram VerstocktIngrid Arijs
- Cited by
- GeneticsImmunologyGastroenterology
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Isabelle Cleynen
94 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 110
- Genetics 1.7k
- Immunology 958
- Gastroenterology 199
- Epidemiology 1.1k
- Cancer Research 325
Countries citing papers authored by Isabelle Cleynen
This map shows the geographic impact of Isabelle Cleynen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Cleynen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Cleynen more than expected).
Fields of papers citing papers by Isabelle Cleynen
This network shows the impact of papers produced by Isabelle Cleynen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Cleynen. The network helps show where Isabelle Cleynen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Isabelle Cleynen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 20 | |
| 4 | 2022 | 9 | |
| 5 | 2020 | 30 | |
| 6 | 2019 | 5 | |
| 7 | 2019 | 8 | |
| 8 | 2017 | 119 | |
| 9 | A variable number of tandem repeat polymorphism in the promotor region of the neonatal Fc receptor affects anti-tumour necrosis factor serum levels in inflammatory bowel disease | 2016 | 2 |
| 10 | 2016 | 124 | |
| 11 | 2016 | 48 | |
| 12 | Disease burden outweighs the impact of drug concentrations and antibodies to infliximab in primary non-response to infliximab in Crohn's disease patients | 2015 | 2 |
| 13 | Anti-TNF-induced skin manifestations in IBD patients: role for increased drug exposure? | 2015 | 1 |
| 14 | 2015 | 47 | |
| 15 | 2015 | 28 | |
| 16 | 2014 | 22 | |
| 17 | 2013 | 22 | |
| 18 | Anti-TNF induced skin manifestations in IBD patients: characterization and search for predisposing factors | 2011 | 5 |
| 19 | Long term evolution and impact of immunomodulator cotreatment and withdrawal on infliximab on trough levels in 223 patients with Crohn's disease | 2011 | 2 |
| 20 | 2011 | 150 |
About Isabelle Cleynen
Isabelle Cleynen is a scholar working on Genetics, Immunology and Epidemiology, having authored 100 papers that have together received 3.2k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (60 papers), Microscopic Colitis (29 papers), Helicobacter pylori-related gastroenterology studies (21 papers), Immunodeficiency and Autoimmune Disorders (14 papers), Autoimmune and Inflammatory Disorders (9 papers), Eosinophilic Esophagitis (7 papers), Gut microbiota and health (6 papers) and Alzheimer's disease research and treatments (5 papers). The work is most often cited by research in Genetics (1.7k citations), Immunology (958 citations) and Gastroenterology (199 citations). Isabelle Cleynen has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Séverine Vermeire, Paul Rutgeerts, Wim Van de Ven, Gert Van Assche, Marc Ferrante, Kristel Van Steen, Bram Verstockt, Ingrid Arijs, Tim Vanuytsel and Frans Schuit.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.